We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Moderate levels of ozone and fine particulate matter were associated with nonviral asthma attacks among children and adolescents living in low-income urban areas, according to a study published in The Lancet Planetary Health.
Exposure to these pollutants also was associated with molecular changes in patients’ airways during nonviral attacks, indicating potential mechanisms behind the attacks, Matthew C. Altman, MD, MPhil, associate professor in the department of medicine, division of allergy and infectious diseases at University of Washington School of Medicine, and colleagues wrote.
Matthew C. Altman
“The NIAID Inner City Asthma Consortium has been studying the asthma epidemic in urban children in low-income households for several decades,” Altman told Healio, adding that viral respiratory infections are well known to trigger asthma exacerbations, although other triggers are less understood.
In previous studies, Altman continued, the researchers noted a surprisingly high rate of nonviral asthma exacerbations in urban children, of which they sought to identify the etiology and mechanisms.
“We found the most relevant factor appeared to be local air pollution exposure, especially to fine particulate matter and ozone, even at relatively moderately elevated levels, and found that they caused exacerbations through unique inflammatory pathways,” Altman said.
Study design, results
Altman and colleagues conducted a secondary analysis of 168 children (98 boys) aged 6 to 17 years with exacerbation-prone asthma from Mechanisms Underlying Asthma Exacerbations Prevented and Persistent with Immune-based Therapy Part 1 (MUPPITS1), a prospective and observational cohort study conducted in low-income urban centers of nine U.S. cities. Researchers followed participants between 2015 and 2017 through two respiratory illnesses or for approximately 6 months, whichever came first.
Those who reported a respiratory illness returned to the clinic twice during the 6-day period after their symptoms had begun for nasal sample collection and pulmonary function testing. The researchers categorized each illness as a viral (V+) or nonviral (V–) event and whether it included (Ex+) or did not include (Ex–) an asthma exacerbation.
Also, the researchers downloaded Air Quality Index (AQI) values and individual data for particulate matter at the 2.5 µm (PM2.5) and 10 µm (PM10) scales, ozone, nitrogen dioxide, sulfur dioxide, carbon monoxide and lead for each city during the study’s timeframe.
There were 336 respiratory events, including 143 Ex+ and 193 Ex– events.
In the 9 days preceding and following the start of respiratory symptoms, AQI values were significantly higher, indicating poorer air quality, for the Ex+ events than they were for the Ex– events (P < .0001).
Overall, 33.8% events with detailed assessments were V–, including 29.8% of Ex+ events.
Patients who were both V– and Ex+ were exposed to increased AQI values during the 9 days before and after their illness compared with V+/Ex+, V+/Ex–, and V–/Ex–patients (P < .0001), with similar AQI values between the three latter subgroups. Researchers noted these exacerbations occurred after several days of mean sustained increase in AQI.
Also, the V–/Ex+ group experienced higher concentrations of ozone (P < .0001), nitrogen dioxide (P < .0001) and PM2.5 (P = .0006) during this timeframe than the other groups, although the V+/Ex+ group had modestly higher ozone concentrations as well (P = .0014).
There was an association between higher AQI and V–/Ex+ events in the spring and summer (P < .0001) and winter and fall (P = .0003) compared with other events, with the most pronounced differences in spring and summer.
AQI and ozone values also had significant inverse associations with percentage of predicted FEV1(FEV1%) and FEV1/forced vital capacity ratio during V–/Ex+ events.
Researchers observed a significant association between cumulative AQI values over 3 days and upper airway gene expression modules associated with incipient asthma exacerbations.
Specifically, PM2.5 concentrations were linked to increased epithelial induction of tissue kallikreins, mucus hypersecretion and barrier functions, and ozone concentrations were associated with increased type-2 inflammation.
Comparisons, next steps
The researchers compared these results against data of 419 inner-city youth aged 6 to 20 years with persistent allergic asthma from the randomized, double-blind, placebo-controlled Inner-City Anti-IgE Therapy for Asthma (ICATA) trial. Of 100 asthma exacerbations in this study, 47 were V–.
Like the MUPPITS1 study, patients experiencing V–/Ex+ events also had been exposed to increased AQI, ozone and PM2.5 values compared with the other subgroups (P < .0001), although the effect of nitrogen dioxide was not significant.
Perhaps the most surprising finding, Altman said, was that these pollutants seemed to be associated with asthma exacerbations at only modestly elevated levels by current EPA guidelines.
“This may indicate that measurements underestimate the exposures these children have in their specific urban environments and/or urban children with asthma are more sensitive to these pollutants than has been previously understood/assumed,” he said.
Also, Altman noted that these exacerbations seemed to proceed through distinct inflammatory pathways from viral exacerbations that may not be fully responsive to some current asthma therapies.
Noting that these findings could inform novel asthma management strategies for children in urban areas, the researchers recommended preventive use of personal air quality monitors and air filers around periods of risk.
“Hopefully, this work can help drive the ongoing recognition of need for mitigating air pollution exposure in these urban and other environments,” Altman said, adding that his team is now investigating methods of asthma prevention and treatment in urban children.
“We will incorporate these results into our ongoing and future studies in particular to better understand why some asthma therapies are effective or ineffective in some children and how this may relate to the type of asthma they have and what their environmental exposures are,” he said.